ASND Ascendis Pharma A/S: fundamentals, insider trades, fund holders

Screener

Quality checklist

4 of 5 checks passed · quarter ending 2026-06-30

ROIC at least 10%26.4%passed
Operating margin up over 3 years+509.1 pppassed
Free cash flow at least 80% of net income—no value
Share count up at most 5% in 3 years19.5%failed
Net debt at most 3× EBITDA-1.5×passed
Revenue grew over 3 years106.3%passed

Insider buying, last 90 days

Not available: foreign companies’ insiders don’t file Form 4 with the SEC.

Tracked funds, latest reports

None of the tracked funds holds it.

Fundamentals

Financials

Insider trades

Fund holders

Each factor with its sector median and, where it's reported per quarter, its last 12 quarters.

Coming as the IEX price history grows (90 trading days so far): Momentum 12-1 (253), Momentum vs. sector (253), Distance from 52-week high (253), Beta (253), Max drawdown 3y (757).

Size & liquidity

ASNDSector 12 quarters Market cap $16.61B$10.87BEnterprise value $16.13B$11.5BAvg daily $ volume —$134.12MDaily turnover —1.3%Relative volume 0.9×0.9×

Growth

ASNDSector 12 quarters Revenue CAGR 3y 106.3%9.5%

Revenue CAGR 5y 190.5%9.2%

Revenue growth YoY 114.7%8.5%

Revenue acceleration −29.6 pp+0.1 pp

FCF growth YoY —4.5%

FCF conversion —128.9%

Forward growth (HoM est.) 50.0%9.6%

Valuation

ASNDSector 12 quarters P/E (trailing) 19.2×27.2×P/E (forward, HoM est.) 12.8×25.0×P/E vs. sector 0.7×1.0×PEG (HoM est.) 0.263.02EV/EBITDA 48.7×17.4×EV/Sales 13.2×3.3×FCF yield —3.7%Dividend yield —0.0%Shareholder yield —1.2%

Quality

ASNDSector 12 quarters Quality checks passed 43ROIC 26.4%9.1%

Gross profitability 41.8%32.8%

Gross margin 91.3%62.2%

Gross margin Δ 3y +11.7 pp+0.0 pp

Operating margin 25.4%10.4%

Operating margin Δ 3y +509.1 pp+0.9 pp

Debt/equity 0.3×0.7×

Net debt/EBITDA -1.5×2.0×

Interest coverage 1.3×4.6×

Share count Δ 3y 19.5%0.1%

Stock compensation / revenue 11.5%1.9%

Accruals ratio 23.3%-4.3%

Momentum & risk

ASNDSector 12 quarters Volatility 30d 23.9%29.5%

Ownership & positioning

ASNDSector 12 quarters Insider buys (90d) —0Insiders buying (90d) —0Insider net value (90d) —$0Institutional ownership —99.3%Institutional Δ QoQ —+1.1 ppConviction funds net buying —+0.0 ppActive managers net buying —+0.1 ppActive funds net buying —+0.0 ppDays to cover —4.29Short % of shares out —6.0%Short interest Δ —+0.1 pp

Share price and valuation

$243.19 on Oct 23, 2026 · +5.3% since Jun 17, 2026

Compare with

Report dates

Daily close

IEX Historical Data: the last regular-session trade on IEX each day, split-adjusted, dividends not added.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Terms of use

Foreign companies' figures are converted to US dollars with exchange rates from the Federal Reserve (H.10), the US Treasury and the European Central Bank. Source: ECB. Terms of use

Share price and valuation ?

Share price and valuation